NeuroRPM

by NeuroRPM Inc.  · Based in United States → — FDA-Cleared & AI-Enabled & Physician Prescribed Parkinson's Management on Apple Watch
Geriatrics Neurology

Regulatory Status Disclosed

Overview

NeuroRPM, developed by New Touch Digital Inc., is an AI-enabled remote patient monitoring platform designed to track and analyze motor symptoms in patients with Parkinson’s disease. Utilizing consumer-facing hardware, the software runs on the Apple Watch and mobile devices to continuously and passively collect movement data during wake periods.

The technology is primarily utilized by:

  • Neurologists and Movement Disorder Specialists: To remotely monitor patients in outpatient care settings, supporting clinical decision-making and treatment discussions.
  • Clinical Researchers and Pharmaceutical Partners: To gather objective, longitudinal digital biomarker data and evaluate treatment responses during clinical trials.

In a clinical workflow, the physician prescribes the application (NeuroRPM-Rx) to the patient. The software operates in the background to detect and quantify core Parkinson’s symptoms, specifically bradykinesia, tremor, and dyskinesia. The platform integrates medication tracking, allowing clinicians to view symptom patterns in relation to daily medication schedules. This objective data is compiled into reports, helping care teams evaluate disease progression, assess medication efficacy, and adjust treatment plans without relying solely on patient self-reporting.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered, real-time detection and visualization of bradykinesia, tremors, and dyskinesias from Apple Watch
  • Medication tracking and insights
  • HealthKit Integration for holistic wellness monitoring
  • Collects accelerometer and gyroscope data from Apple Watch
  • Analyzes motion data using machine learning models to generate binary symptom classifications every 15 minutes
  • Provides monthly reports
  • Companion Mode for sharing health information with family/caregivers (with consent)

Use Cases

  • Quantifying movement disorder symptoms in Parkinson's disease patients (tremor, bradykinesia, dyskinesia)
  • Medication management for Parkinson's disease
  • Remote patient monitoring in clinic and home environments
  • Therapy research and development for symptom control and disease modification
  • Supporting data-driven care and improving patient management in neurology practices

Details

Category Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentMobile app (Apple Watch and iPhone)
Mobile AppYes (iOS for iPhone and Apple Watch)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Geriatrics, Neurology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2023-03-17K221772 510(k)NeuroRPM

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate NeuroRPM

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for NeuroRPM.

Loading videos...

View all on YouTube

Frequently Asked Questions

NeuroRPM-Rx is an AI-enabled solution that uses Apple Watch data and mobile software to monitor key Parkinson's motor symptoms like bradykinesia, tremor, and dyskinesia. The AI helps detect and visualize these symptom patterns over time, providing objective data to support clinical decisions.
NeuroRPM-Rx is FDA-Cleared, indicating it meets regulatory standards for medical devices. Additionally, NeuroRPM Inc. is committed to protecting user privacy and handles personal and health information responsibly, with a comprehensive Privacy Policy and HIPAA Notice of Privacy Practices in place.
The provided text does not mention any specific alternatives to NeuroRPM-Rx for Parkinson's monitoring. It focuses solely on the features and benefits of NeuroRPM-Rx and NeuroRPM-CT.
The provided official website text does not contain any information regarding the pricing of NeuroRPM-Rx. Physicians interested in using the service are directed to a sign-up page to learn more and get started.
The provided text does not explicitly detail any limitations of NeuroRPM-Rx. It highlights its capabilities in objective symptom monitoring, medication tracking, and clinical care support for Parkinson's motor symptoms.
NeuroRPM-Rx provides physicians and care teams with objective data to help inform treatment discussions, medication adjustments, and ongoing disease management. It supports medication tracking and supplemental health data integration, aiming to provide a clearer view of symptom patterns over time for clinical care.
NeuroRPM-Rx is designed to monitor key Parkinson's motor symptoms, specifically including bradykinesia, tremor, and dyskinesia, using data collected from an Apple Watch.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-17 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.